Significant association of interleukin-10 genotypes and oral cancer susceptibility in Taiwan

Anticancer Research

Volumn 34, Issue 7, 2014, Pages 3731-3737

  Tsai, Chia Wen ^a,b   Chang, Wen Shin ^b   Lin, Kuo Cheng ^b   Shih, Liang Chun ^b   Tsai, Ming Hsui ^b   Hsiao, Chieh Lun ^b   Yang, Mei Due ^b   Lin, Cheng Chieh ^b   Bau, Da Tian ^a,b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Carcinogenesis; IL10; Oral cancer; Polymorphism

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; IL10 PROTEIN, HUMAN;

ADULT; ARECA; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HIGH RISK BEHAVIOR; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MASTICATION; MOUTH CANCER; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TAIWAN; TUMOR ESCAPE; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; IL10; IMMUNOLOGY; MIDDLE AGED; MOUTH TUMOR; NASOPHARYNX TUMOR; POLYMORPHISM; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

CARCINOGENESIS; IL10; ORAL CANCER; POLYMORPHISM;

CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TAIWAN;

EID: 84906328259     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Department of Health Taiwan (2012) Cancer Registration System Annual Report. Taiwan, Department of Health.
3. Chung CH, Yang YH, Wang TY, Shieh TY and Warnakulasuriya S: Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J Oral Pathol Med 34: 460-466, 2005.
4. Lee CH, Ko YC, Huang HL, Chao YY, Tsai CC, Shieh TY and Lin LM: The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br J Cancer 88: 366-372, 2003.
5. Chen PC, Kuo C, Pan CC and Chou MY: Risk of oral cancer associated with human papillomavirus infection, betel quid chewing, and cigarette smoking in Taiwan-an integrated molecular and epidemiological study of 58 cases. J Oral Pathol Med 31: 317-322, 2002.
6. Mocellin S, Marincola FM and Young HA: Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol 78: 1043-1051, 2005.
7. Uwatoko N, Tokunaga T, Hatanaka H, Osada H, Kawakami T, Yamazaki H, Abe Y, Kijima H, Ueyama Y and Nakamura M: Expression of interleukin-10 is inversely correlated with distant metastasis of renal cell carcinoma. Int J Oncol 20: 729-733, 2002.
8. Neuner A, Schindel M, Wildenberg U, Muley T, Lahm H and Fischer JR: Prognostic significance of cytokine modulation in non-small cell lung cancer. Int J Cancer 101: 287-292, 2002.
9. Kozlowski L, Zakrzewska I, Tokajuk P and Wojtukiewicz MZ: Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL10) in blood serum of breast cancer patients. Rocz Akad Med Bialymst 48: 82-84, 2003. (Poland)
10. De Vita F, Orditura M, Galizia G, Romano C, Roscigno A, Lieto E and Catalano G: Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients. Chest 117: 365-373, 2000.
11. Budiani DR, Hutahaean S, Haryana SM, Soesatyo MH and Sosroseno W: Interleukin-10 levels in Epstein-Barr virus-associated nasopharyngeal carcinoma. J Microbiol Immunol Infect 35: 265-268, 2002.
12. Yamamoto T, Kimura T, Ueta E, Tatemoto Y and Osaki T: Characteristic cytokine generation patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns. Oncology 64: 407-415, 2003.
13. Kingo K, Ratsep R, Koks S, Karelson M, Silm H and Vasar E: Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility. J Dermatol Sci 37: 111-113, 2005.
14. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ and Hutchinson IV: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24: 1-8, 1997.
15. Tseng LH, Lin MT, Shau WY, Lin WC, Chang FY, Chien KL, Hansen JA, Chen DS and Chen PJ: Correlation of interleukin-10 gene haplotype with hepatocellular carcinoma in Taiwan. Tissue Antigens 67: 127-133, 2006.
16. Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Eder T, Koppel H, Wascher TC, Paulweber B and Samonigg H: Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk. Breast Cancer Res Treat 90: 113-115, 2005.
17. Havranek E, Howell WM, Fussell HM, Whelan JA, Whelan MA and Pandha HS: An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma. J Urol 173: 709-712, 2005.
18. Wei YS, Kuang XH, Zhu YH, Liang WB, Yang ZH, Tai SH, Zhao Y and Zhang L: Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma. Tissue Antigens 70: 12-17, 2007.
19. Tsai CW, Tsai MH, Shih LC, Chang WS, Lin CC, and Bau DT: Associations of interleukin-10 (IL10 ) promoter genotypes with nasopharyngeal carcinoma risk in Taiwan. Anticancer Res 33: 3391-3396, 2013.
20. Yao JG, Gao LB, Liu YG, Li J and Pang GF: Genetic variation in interleukin-10 gene and risk of oral cancer. Clin Chim Acta 388: 84-88, 2008.
21. Hsia TC, Tsai CW, Liang SJ, Chang WS, Lin LY, Chen WC, Tu CY, Tsai CH and Bau DT: Effects of ataxia telangiectasia mutated (ATM ) genotypes and smoking habits on lung cancer risk in Taiwan. Anticancer Res 33: 4067-4071, 2013.
22. Chang WS, Tsai CW, Ji HX, Wu HC, Chang YT, Lien CS, Liao WL, Shen WC, Tsai CH and Bau DT: Associations of cyclooxygenase 2 polymorphic genotypes with bladder cancer risk in Taiwan. Anticancer Res 33: 5401-5405, 2013.
23. Wang CH, Lai YL, Chang WS, Wu KH, Lane HY, Chiu CF, Tsai FJ, Lin CC and Bau DT: Significant association of caveolin-1 single nucleotide polymorphisms with childhood leukemia in Taiwan. Cancer Genomics Proteomics 10: 75-79, 2013.
24. Pratesi C, Bortolin MT, Bidoli E, Tedeschi R, Vaccher E, Dolcetti R, Guidoboni M, Franchin G, Barzan L, Zanussi S, Caruso C and De Paoli P: Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother 55: 23-30, 2006.
25. Lee JY, Kim HY, Kim KH, Kim SM, Jang MK, Park JY, Lee JH, Kim JH and Yoo JY: Association of polymorphism of IL10 and TNFA genes with gastric cancer in Korea. Cancer Lett 225: 207-214, 2005.
26. Ide A, Kawasaki E, Abiru N, Sun F, Takahashi R, Kuwahara H, Fujita N, Kita A, Oshima K, Sakamaki H, Uotani S, Yamasaki H, Yamaguchi Y and Eguchi K: Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset. Hum Immunol 63: 690-695, 2002.
27. Scassellati C, Zanardini R, Squitti R, Bocchio-Chiavetto L, Bonvicini C, Binetti G, Zanetti O, Cassetta E and Gennarelli M: Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease. Neurosci Lett 356: 119-122, 2004.
28. Mangia A, Santoro R, Piattelli M, Pazienza V, Grifa G, Iacobellis A and Andriulli A: IL10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine 25: 103-109, 2004.
29. von Euw EM, Barrio MM, Furman D, Levy EM, Bianchini M, Peguillet I, Lantz O, Vellice A, Kohan A, Chacon M, Yee C, Wainstok R and Mordoh J: A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL10-1082 promoter genotype as predictor of disease progression. J Transl Med 6: 6, 2008.
30. Seifart C, Plagens A, Dempfle A, Clostermann U, Vogelmeier C, von Wichert P and Seifart U: TNF-α, TNF-β, IL6, and IL10 polymorphisms in patients with lung cancer. Dis Markers 21: 157-165, 2005.
31. Shih CM, Lee YL, Chiou HL, Hsu WF, Chen WE, Chou MC and Lin LY: The involvement of genetic polymorphism of IL10 promoter in non-small cell lung cancer. Lung Cancer 50: 291-297, 2005.
32. Stanczuk GA, Sibanda EN, Perrey C, Chirara M, Pravica V, Hutchinson IV and Tswana SA: Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL10 production. Int J Cancer 94: 792-794, 2001.
33. Pooja S, Chaudhary P, Nayak LV, Rajender S, Saini KS, Deol D, Kumar S, Bid HK and Konwar R: Polymorphic variations in IL1β, IL6 and IL10 genes, their circulating serum levels and breast cancer risk in Indian women. Cytokine 60: 122-128, 2012.
34. Kesarwani P, Ahirwar DK, Mandhani A, Singh AN, Dalela D, Srivastava AN and Mittal RD: IL10 -1082 G>A: a risk for prostate cancer but may be protective against progression of prostate cancer in North Indian cohort. World J Urol 27: 389-396, 2009.
35. Zeng X, Li Y, Liu T and Zhang J: Diverse H. pylori strains, IL10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China. Mol Cell Biochem 362: 241-248, 2012.
36. Lu W, Pan K, Zhang L, Lin D, Miao X and You W: Genetic polymorphisms of interleukin (IL)-1B, IL1RN, IL8, IL10 and tumor necrosis factor-α and risk of gastric cancer in a Chinese population. Carcinogenesis 26: 631-636, 2005.
37. Pan F, Tian J, Pan YY and Zhang Y: Association of IL10-1082 promoter polymorphism with susceptibility to gastric cancer: evidence from 22 case-control studies. Mol Biol Rep 39: 7143-7154, 2012.
38. Kang JM, Kim N, Lee DH, Park JH, Lee MK, Kim JS, Jung HC and Song IS: The effects of genetic polymorphisms of IL-6, IL-8, and IL10 on Helicobacter pylori-induced gastroduodenal diseases in Korea. J Clin Gastroenterol 43: 420-428, 2009.
39. Farhat K, Hassen E, Gabbouj S, Bouaouina N and Chouchane L: Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma. Int J Immunogenet 35: 197-205, 2008.
40. Barbisan G, Perez LO, Contreras A and Golijow CD: TNF-α and IL10 promoter polymorphisms, HPV infection, and cervical cancer risk. Tumour Biol 33: 1549-1556, 2012.
41. Ioana Braicu E, Mustea A, Toliat MR, Pirvulescu C, Konsgen D, Sun P, Nurnberg P, Lichtenegger W and Sehouli J: Polymorphism of IL-1α, IL-1β and IL10 in patients with advanced ovarian cancer: results of a prospective study with 147 patients. Gynecol Oncol 104: 680-685, 2007.
42. Faupel-Badger JM, Kidd LC, Albanes D, Virtamo J, Woodson K and Tangrea JA: Association of IL10 polymorphisms with prostate cancer risk and grade of disease. Cancer Causes Control 19: 119-124, 2008.